6850.TWO
Price:
$41.25
Market Cap:
$1.36B
BiOptic Inc., a biotechnology instrumentation company, develops scientific products for research and clinical applications. It offers instruments, such as bio-fragment analyzers and PCR thermocyclers; consumables, including DNA, RNA, and protein cartridges, as well as quantification kits; premix and polymerase PCR reagents; and veterinary, human, and food related testing kits. BiOptic Inc.was founded in 1993 and is headquartered in New Taipei City, Taiwan.
Industry
Biotechnology
IPO Date
2021-11-10
Stock Exchange
TWO
Ticker
6850.TWO
According to BiOptic Inc.’s latest financial reports and current stock price. The company's current ROE is 4.93%. This represents a change of 78.84% compared to the average of 2.76% of the last 4 quarters.
The mean historical ROE of BiOptic Inc. over the last ten years is 7.91%. The current 4.93% ROE has changed -37.67% with respect to the historical average. Over the past ten years (40 quarters), 6850.TWO's ROE was at its highest in in the December 2022 quarter at 8.96%. The ROE was at its lowest in in the June 2021 quarter at 0%.
Average
7.91%
Median
8.74%
Minimum
0%
Maximum
14.64%
Discovering the peaks and valleys of BiOptic Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 14.64%
Minimum Annual Increase = 0%
Minimum Annual ROE = 0%
| Year | ROE | Change |
|---|---|---|
| 2024 | 5.05% | -42.19% |
| 2023 | 8.74% | -40.29% |
| 2022 | 14.64% | 16.52% |
| 2021 | 12.57% | -12.74% |
| 2020 | 14.40% | Infinity% |
| 2019 | 0% | 0% |
The current ROE of BiOptic Inc. (6850.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.48%
5-year avg
11.08%
10-year avg
7.91%
BiOptic Inc.’s ROE is greater than GeneReach Biotechnology Corp. (-19.92%), greater than Great Novel Therapeutics Biotech & Medicals (-14.66%), greater than Enimmune corporation (-70.32%), greater than NaviFUS Corp. (-20.73%), less than Taiwan Advance Bio-Pharmaceutical Inc. (9.19%), less than GenMont Biotech Incorporation (1.18%), greater than MegaPro Biomedical Co., Ltd (-91.17%), greater than Abnova (Taiwan) Corporation (-0.51%), greater than NeoCore Technology Co., Ltd. (-5.81%), greater than LabTurbo Biotech Corporation (-12.54%),
| Company | ROE | Market cap |
|---|---|---|
| -19.92% | $1.10B | |
| -14.66% | $1.48B | |
| -70.32% | $1.44B | |
| -20.73% | $1.45B | |
| 9.19% | $1.05B | |
| 1.18% | $1.59B | |
| -91.17% | $1.02B | |
| -0.51% | $1.38B | |
| -5.81% | $1.52B | |
| -12.54% | $1.12B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BiOptic Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BiOptic Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BiOptic Inc.'s ROE?
How is the ROE calculated for BiOptic Inc. (6850.TWO)?
What is the highest ROE for BiOptic Inc. (6850.TWO)?
What is the 3-year average ROE for BiOptic Inc. (6850.TWO)?
What is the 5-year average ROE for BiOptic Inc. (6850.TWO)?
How does the current ROE for BiOptic Inc. (6850.TWO) compare to its historical average?